-
Thyroid dysfunction and disease might present as reproductive compromise including oligomenorrhea, infertility, and miscarriage.
-
The Food and Drug Administration (FDA) has scheduled a Dec. 8, 2011, meeting of its Reproductive Health Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee to review the risks and benefits of oral contraceptives containing the progestin drospirenone. The agency is weighing evidence regarding the risk of increased blood clots in users of such pills.
-
According to the Centers for Disease Control and Prevention, female adolescents have the highest number of cases of gonorrhea and chlamydia in the United States.1 While the overall prevalence for these infections among individuals ages 14-39 are .24% and 2.2% respectively, these rates are .92% and 3.4% for those ages 14-19.2
-
If your clinical practice includes the care of age 50-plus women, are you including information on risks for sexually transmitted infections (STIs)? You should.
-
The objective of the Endometriosis: Natural History, Diagnosis, and Outcomes (ENDO) study funded by the National Institute of Child Health and Human Development was to estimate the incidence of endometriosis.
-
How can your clinic reach more women at risk for chlamydia and gonorrhea? Take a tip from the Sexually Transmitted Disease (STD) Program at the Los Angeles County Department of Public Health, which is expanding its popular "I Know" at-home testing program in a further outreach to the community.
-
Check your pharmacy stock, and review patient pill choices: A nationwide recall of multiple lots of Qualitest oral contraceptives (OCs) has been issued after the Huntsville, AL-based manufacturer detected a packaging error that could lead to incorrect administration of pills.
-
While intrauterine devices (IUDs) represent a safe, effective, and reversible form of birth control, results of a new study indicate many U.S. women choose sterilization immediately postpartum.
-
The primary objective of this prospective cohort study was to evaluate the malignant potential of ultrasound-detected ovarian inclusion cysts in the development of ovarian cancer in menopausal women participating in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) study.
-
The objective of the nichd-funded endo study was to estimate the incidence of endometriosis. The investigators used a matched-exposure cohort design to delineate the burden of endometriosis among women scheduled for surgical care and in the general population from the catchment areas of several surgical centers in the Salt Lake City and San Francisco areas. All subjects in both groups were currently menstruating women aged 1844 years without a prior surgical diagnosis of endometriosis.
